Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
CCG-1423: RhoA Inhibitor Workflows for Cancer & Viral Resear
2026-07-16
CCG-1423, a potent RhoA inhibitor from APExBIO, uniquely enables researchers to dissect RhoA/ROCK signaling in both cancer and viral infection models. This guide delivers protocol-ready workflows, troubleshooting insights, and practical applications based on cutting-edge reference studies.
-
Carbapenemase Gene Transmission in CREC During COVID-19: Ins
2026-07-16
This study systematically examines the prevalence and transfer dynamics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, during the COVID-19 pandemic. The findings reveal dominant plasmid-borne blaNDM-1, high multidrug resistance, and efficient horizontal gene transfer, informing antimicrobial resistance surveillance and intervention strategies.
-
Poly (I:C): Synthetic Double-Stranded RNA Analog in Immunity
2026-07-15
Poly (I:C), a synthetic double-stranded RNA analog, is redefining experimental immunity by enabling robust interferon induction and precise dendritic cell maturation. Its versatility across mammalian and plant systems, combined with APExBIO's reproducible formulation, delivers translational impact and workflow reliability for cutting-edge immunology and antiviral studies.
-
Dual-Action Airway Stents Suppress Tracheal Restenosis via I
2026-07-15
The referenced study introduces an airway stent that combines anti-inflammatory and anti-angiogenic functions to address tracheal in-stent restenosis (TISR), a persistent complication in airway interventions. Through advanced material engineering and in vivo validation, the stent demonstrates significant suppression of fibrosis, angiogenesis, and inflammation, offering new translational avenues for airway stenting.
-
EMD638683: Unraveling SGK1 Inhibition in Precision Vascular
2026-07-14
Explore the nuanced role of EMD638683 as a selective SGK1 inhibitor in vascular stiffness and cell proliferation research. This article provides a technical deep dive into mechanism, assay design, and translational implications, setting a new standard beyond existing SGK inhibitor overviews.
-
Ibotenic Acid in Translational Neurodegeneration: Mechanisti
2026-07-14
Explore how ibotenic acid, a potent NMDA receptor agonist, enables advanced modeling of neurodegenerative disorders. This in-depth article reveals new assay considerations, mechanistic findings, and practical protocol refinements for neuroscience research.
-
Ionomycin Free Acid: Advanced Calcium Ionophore Workflows in
2026-07-13
Ionomycin free acid empowers precise intracellular calcium modulation for cell signaling and reproductive biology research. This guide translates recent mechanistic insights—especially from FAK pathway studies—into actionable workflows and troubleshooting strategies, highlighting APExBIO’s reagent reliability for demanding experimental needs.
-
Canagliflozin (hemihydrate): Precision in SGLT2 Research Ass
2026-07-13
Explore the unique assay utility of Canagliflozin (hemihydrate) as a high-purity SGLT2 inhibitor in metabolic research. This article delivers advanced protocol guidance and critical analysis of selectivity beyond mTOR pathways, supporting reproducibility in diabetes and glucose homeostasis studies.
-
Carrier-Free Triterpene Prodrugs for Targeted OSCC Therapy
2026-07-12
This study introduces a self-assembled, carrier-free triterpene prodrug platform for oral squamous cell carcinoma (OSCC) chemotherapy. By leveraging ROS-responsive linkers and dual triterpene synergy, the approach achieves targeted drug delivery, enhanced tumor cell selectivity, and self-boosted drug release.
-
BMN 673 (Talazoparib): PARP Inhibition, Spliceosome, and HCC
2026-07-10
Explore how BMN 673 (Talazoparib) advances cancer research by linking PARP inhibition with spliceosome regulation and hepatocellular carcinoma sensitivity. This article uncovers unique mechanistic insights and practical assay implications for DNA repair deficiency targeting.
-
2'3'-cGAMP (sodium salt): Precision Modulation of STING Path
2026-07-09
Explore how 2'3'-cGAMP (sodium salt) enables precise, reproducible activation of STING-mediated innate immune responses. This article uniquely dissects the molecular interplay between REC8, STING, and cGAS, offering new insights for immunology and antiviral research.
-
PSMD14-CARM1 Axis Drives HCC Progression via FERMT1 Activati
2026-07-09
This study elucidates how PSMD14-mediated deubiquitination stabilizes CARM1, promoting hepatocellular carcinoma (HCC) growth and metastasis by transcriptionally activating FERMT1. These findings clarify the molecular mechanisms underlying CARM1’s oncogenic role in HCC and highlight potential targets for therapeutic intervention.
-
Resolving Cell Assay Challenges with β-Elemene (SKU C5505)
2026-07-08
This article addresses real-world laboratory challenges in cell viability, adipogenesis, and cytotoxicity assays, demonstrating how β-Elemene (SKU C5505) from APExBIO serves as a reliable, mechanistically validated solution. Scenario-driven Q&As provide evidence-backed guidance on protocol design, data interpretation, and product selection for advanced biomedical research.
-
DNase I (RNase-free): Precision DNA Removal for RNA Purity
2026-07-08
Unlock next-level RNA extraction and RT-PCR reliability with DNase I (RNase-free), a robust, cation-dependent enzyme trusted by leading oncology labs. Learn how optimized workflows and troubleshooting strategies can elevate your results, especially in challenging tumor microenvironment models.
-
Protease Inhibitors Block Light-Induced Stomatal Opening in
2026-07-07
Wang et al. identified specific protease inhibitors that suppress light-induced stomatal opening in Commelina benghalensis, revealing a role for protease activity in guard cell signaling. Their chemical screening approach advances our understanding of how protease inhibition modulates plant physiological responses, with broader implications for chemical biology and high-throughput screening strategies.